Shares of CVS Health (NYSE:CVS) traded marginally lower on Friday after rising from a low of $62.92 from past six trading sessions, where shares grew overall 6% to a high of $66.63. Today’s the stock ...
Humana stock fell early Friday after the U.S. government released quality ratings for Medicare plans, and an analyst ...
On Oct. 8, Keybanc analyst John Vinh maintained Micron Technology with an Overweight and lowered the price target from $145 ...
Fintel on MSN17h
Barclays Upgrades CVS Health (CVS)Fintel reports that on October 10, 2024, Barclays upgraded their outlook for CVS Health (NYSE:CVS) from Equal-Weight to ...
Sixty-two percent of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans ...
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback